Alternative Treatments of Breakthrough Pain in Patients Receiving Spinal Analgesics for Cancer Pain
- 30 November 2005
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 30 (5) , 485-491
- https://doi.org/10.1016/j.jpainsymman.2005.04.014
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Local Anesthetics for Breakthrough Pain in Patients Receiving Intrathecal Treatment for Cancer Pain ManagementAnesthesia & Analgesia, 2005
- Dialogues on complex analgesic strategies for difficult pain syndromesSupportive Care in Cancer, 2004
- Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine doseJournal of Pain and Symptom Management, 2004
- Episodic (breakthrough) painCancer, 2002
- Morphine and alternative opioids in cancer pain: the EAPC recommendationsBritish Journal of Cancer, 2001
- Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)PAIN®, 2001
- Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration studyPain, 1999
- Problems of long-term spinal opioid treatment in advanced cancer patientsPain, 1999
- Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.Journal of Clinical Oncology, 1998
- Breakthrough pain: definition, prevalence and characteristicsPAIN®, 1990